Category: CNS/Neurology
Global CNS/Neurology
-
Global Central Nervous System (CNS) Stimulant Drugs Market 2025-2029
... period. The report on the central nervous system (CNS) stimulant drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
Robotic-Assisted Neurosurgery System Market Size, Share, and Trends Analysis - Global - 2025-2031 - MedCore - Includes: Capital Equipment Market, Services and Maintenance Revenue Market
... into: Capital Equipment Services & Maintenance Revenue Market Insights & Data Coverage Unit Sales & Average Selling Prices Market Size & Growth Trends Procedure Numbers Market Drivers & Limiters Market Forecasts Until 2031 Historical Data ... Read More
-
Neurosurgery Navigation Systems Market Size, Share, & Trend Analysis - Global - 2025-2031 - MedCore - Includes: Capital Equipment, and 2 more
... segments: Capital equipment Disposables & other accessories Service & maintenance revenue Market insights & data coverage Unit sales & average selling prices Market size & growth trends Procedure numbers Market drivers & limiters Market forecasts ... Read More
-
Cranial Fixation and Stabilization Systems
... Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Cranial Stabilization Systems, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$987.5 ... Read More
-
Intracranial Aneurysm
... CAGR of 8.7% over the analysis period 2024-2030. Endovascular Coiling, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Anxiety Disorder Treatment
... at a CAGR of 2.4% over the analysis period 2024-2030. Antidepressants, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$4.9 Billion by the end of the ... Read More
-
Narcolepsy Therapeutics
... CAGR of 7.1% over the analysis period 2024-2030. Narcolepsy with Cataplexy Therapeutics, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.9 Billion by the end of ... Read More
-
CNS Therapeutics
... CAGR of 7.3% over the analysis period 2024-2030. Neurodegenerative Diseases Therapeutics, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$75.9 Billion by the end of the ... Read More
-
Bipolar Disorder Therapeutics
... at a CAGR of 3.4% over the analysis period 2024-2030. Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by the end of ... Read More
-
Interventional Neurology Devices
... at a CAGR of 4.6% over the analysis period 2024-2030. Cerebral Embolization & Aneurysm Coiling, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.0 Billion by ... Read More
-
Psychiatric and Substance Abuse Hospitals
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Alcoholism Rehabilitation Hospitals, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$13.5 ... Read More
-
Biosimulation Market by Offering (Module, Integrated Platform), Application (Disease Modeling, PBPK, PKPD, Trial Simulation, Manufacturing & Supply chain: planning & forecasting), Indication (Cancer, CNS, CVS), End User, & Region - Global Forecast to 2029
... the drug development process has been one of the major drivers in the adoption of biosimulation tools. These tools predict how the drugs will behave inside the human body, potentially minimizing the requirements of extensive ... Read More
-
Amyotrophic Lateral Sclerosis
... at a CAGR of 19.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$345.9 Million While China is Forecast to Grow at 18.4% CAGR The Amyotrophic Lateral Sclerosis market in the U.S. ... Read More
-
Antipsychotic Drugs
... CAGR of 6.8% over the analysis period 2024-2030. Second Generation Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$15.7 Billion by the end of ... Read More
-
Brain Computer Interface
... at a CAGR of 10.3% over the analysis period 2024-2030. Invasive BCI, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Neurology Devices
... CAGR of 5.9% over the analysis period 2024-2030. Cerebrospinal Fluid Management, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$7.1 Billion by the end of the ... Read More
-
Prescription Drugs
... CAGR of 5.7% over the analysis period 2024-2030. Generic Drugsone of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$498.0 Billion by the end of the analysis period. ... Read More
-
EEG, EMG and Evoked Potential Devices
... reach US$1.7 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Electroencephalograph Equipment, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach ... Read More
-
Migraine Drugs
... CAGR of 16.0% over the analysis period 2024-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$7.2 Billion by the end of the analysis ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics
... reach US$57.7 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Stimulant Drugs, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach ... Read More
-
Tourette Syndrome Treatment Global Market Opportunities And Strategies To 2033
... Inc.; Eli Lilly and Company; H. Lundbeck AS; Bayer AG Tourette Syndrome Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical ... Read More
-
Global Antipsychotic Drugs Market - 2025-2032
... forecast period 2025-2032. Antipsychotic medications are an important class of psychiatric drugs prescribed to manage psychosis, which includes symptoms such as delusions, hallucinations, and disorganized thinking. These medications are primarily used to treat conditions like ... Read More
-
Global Oxidative Stress Assay Market - 2025 - 2033
... of 9.7% during the forecast period 2025-2032. Oxidative Stress Assays, commonly known as painkillers, are a class of drugs designed to relieve pain. They work by blocking pain signals in the body or by altering ... Read More
-
Global Lucid Dreaming Devices Market - 2025 - 2033
... of 5.8% during the forecast period 2025-2033. Lucid dreaming devices are devices that help individuals recognize and control their dream state by monitoring sleep patterns and delivering sensory cues during specific stages of sleep, often ... Read More
-
Migraine Market Research Report Information by Type (Episodic and Chronic), By Treatment Type (Preventive, Abortive), By Drug Class (Triptans, Ergots, and Others), And by Region (North America, Europe, Asia-Pacific, And Rest of The World) Industry Forecast Till 2032
... from USD 6.00 Billion in 2024 to USD 8.42 Billion by 2032. The primary market drivers that are fostering market growth are the global increase in migraine problems and the increasing public awareness of novel ... Read More
Research Assistance
